CEA

About the Test

CEA - Increased serum CEA levels have been detected in persons with primary colorectal cancer and in patients with other malignancies involving the gastrointestinal tract, breast, lung, ovarian, prostatic, liver and pancreatic cancers. Elevated serum CEA levels have also been detected in patients with nonmalignant disease, especially patients who are older or who are smokers. CEA levels are not useful in screening the general population for undetected cancers. However, CEA levels provide important information about patient prognosis, recurrence of tumors after surgical removal, and effectiveness of therapy.

Biomarkers

Carcinoembryonic Antigen

Biomarker name

Related Articles

Related Tests

PSA, Total (mcr Scr)

 by 

Access Med Labs

Serum

This is a single-marker test measuring total PSA. It is useful for monitoring recurrence and response to treatment in patients with a history of prostate cancer. Elevated levels have been reported in inflammatory conditions of the prostate, benign prostatic hypertrophy, and prostate cancer.

PSA Free and Total

 by 

Access Med Labs

Serum

This test measures free and total prostate-specific antigen (PSA).

PSA, Free and Total

 by 

Access Labcorp Draw

Serum

This test measures free and total prostate-specific antigen (PSA).

Prostate-Specific Antigen (PSA)

 by 

Access Labcorp Draw

Serum

This is a single-marker test measuring prostate-specific antigen (PSA). It can be used as a tumor marker for the early detection of prostate cancer and in other areas of prostate disease management.

PSA, Total

 by 

Boston Heart

Serum

This is a single-marker test measuring prostate-specific antigen (PSA). It can be used as a tumor marker for the early detection of prostate cancer and in other areas of prostate disease management. Please be advised that Boston Heart Diagnostics policy states that practitioners cannot order labs on themselves or their immediate family members.